Abstract Mesenchymal Stem Cells (MSCs) have been studied extensively for the treatment
of several retinal diseases. The therapeutic potential of MSCs lies in its ability to differentiate …

Stem cell-based treatments have been extensively explored in the last few decades to
develop therapeutic strategies aimed at providing effective alternatives for those human …

Diabetic retinopathy (DR), a complication of diabetes, is one of the leading causes of
blindness in working-age adults. The pathology of the disease prevents the endogenous …

Diabetic retinopathy (DR) is a multifactorial microvascular disease induced by
hyperglycemia and subsequent metabolic abnormalities. The resulting cell stress causes a …

Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated
with several complications. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) …

Multipotent mesenchymal stem/stromal cells (MSCs) have regenerative and
immunomodulatory properties to restore and repair injured tissues, making them attractive …

Diabetic retinopathy (DR) is an important microvascular complication of diabetes mellitus
(DM), causing significant visual impairment worldwide. Current gold standards for retarding …

The skin is the largest organ of the human body and is the first line of defense against
physical and biological damage. Thus, the skin is equipped to self-repair and regenerates …

Stem cell therapies have shown promising therapeutic effects in restoring damaged tissue
and promoting functional repair in a wide range of human diseases. Generations of insulin …

Angiogenesis is a biological process with a central role in retinal diseases. The choice of the
ideal method to study angiogenesis, particularly in the retina, remains a problem …